Two trials, SOFT and TEXT, investigating combination treatments for patients with breast cancer
The future of lung cancer management: an unmet need in the immuno-oncology era
Using biomarkers to identify bladder cancer patients for neoadjuvant therapy
Pharmacist's advice on biomarkers for immunotherapy
R. Donald Harvey
HOPA 2018/19: what’s next?